Log In
Print
BCIQ
Print
Print this Print this
 

Endostar, Endu

  Manage Alerts
Collapse Summary General Information
Company Simcere Pharmaceutical Group
DescriptionRecombinant human endostatin injection
Molecular Target Endostatin
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today